How a Pacific vaccine innovator became the first low- or middle-income country to reduce its pneumococcal vaccine schedule from three doses to two For more than a decade, Fiji has protected its children against pneumococcal disease with three doses of pneumococcal conjugate vaccine, or PCV. In 2026, the Pacific nation is preparing to become the first low- or middle-income country to move to a two dose PCV schedule: one dose in infancy followed b…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.